Literature DB >> 25207010

Polymorphisms of cytochrome p450 genes in three ethnic groups from Russia.

Gülnaz Korytina1, Olga Kochetova1, Leysan Akhmadishina1, Elena Viktorova2, Tatyana Victorova1.   

Abstract

OBJECTIVE: To determine the prevalence of the most common allelic variants of CYP1A1, CYP1A2, CYP1B1, CYP2C9, CYP2E1, CYP2F1, CYP2J2 and CYP2S1 in a representative sample of the three ethnic groups (Russians, Tatars and Bashkirs) from Republic of Bashkortostan (Russia), and compare the results with existing data published for other populations.
MATERIAL AND METHODS: CYPs genotypes were determined in 742 DNA samples of healthy unrelated individuals representative of three ethnic groups. The CYPs gene polymorphisms were examined using the PCR-RLFP method.
RESULTS: Analysis of the CYP1A1 (rs1048943, rs4646903), CYP1A2 (rs762551), CYP2E1 (rs2031920) allele, genotype and haplotype frequencies revealed significant differences among healthy residents of the Republic of Bashkortostan of different ethnicities. Distribution of allele and genotype frequencies of CYP1A2 (rs35694136), CYP1B1 (rs1056836), CYP2C9 (rs1799853, rs1057910), CYP2F1 (rs11399890), CYP2J2 (rs890293), CYP2S1 (rs34971233, rs338583) genes were similar in Russians, Tatars, and Bashkirs. Analysis of the CYPs genes allele frequency distribution patterns among the ethnic groups from the Republic of Bashkortostan in comparison with the different populations worldwide was conducted.
CONCLUSION: The peculiarities of the allele frequency distribution of CYPs genes in the ethnic groups of the Republic of Bashkortostan should be taken into consideration in association and pharmacogenetic studies. The results of the present investigation will be of great help in elucidating the genetic background of drug response, susceptibility to cancer and complex diseases, as well as in determining the toxic potentials of environmental pollutants in our region.

Entities:  

Keywords:  Pharmacogenetics; ethnic-related differences CYPs variants in three ethnic groups from Russia; genetic polymorphism

Year:  2012        PMID: 25207010      PMCID: PMC4115825          DOI: 10.5152/balkanmedj.2012.039

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  41 in total

Review 1.  Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19.

Authors:  S M Hoffman; D R Nelson; D S Keeney
Journal:  Pharmacogenetics       Date:  2001-11

2.  Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.

Authors:  D Krishnakumar; Umamaheswaran Gurusamy; Kayathri Dhandapani; A Surendiran; Ruchi Baghel; Ritushree Kukreti; Reneega Gangadhar; Ushakiran Prayaga; S Manjunath; C Adithan
Journal:  Fundam Clin Pharmacol       Date:  2011-01-25       Impact factor: 2.748

3.  Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.

Authors:  Sofia Pavanello; Alessandra Pulliero; Silvia Lupi; Pasquale Gregorio; Erminio Clonfero
Journal:  Mutat Res       Date:  2005-09-26       Impact factor: 2.433

4.  Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant.

Authors:  Gilles Tournel; Christelle Cauffiez; Ingrid Billaut-Laden; Delphine Allorge; Dany Chevalier; Fabien Bonnifet; Eric Mensier; Jean-Jacques Lafitte; Michel Lhermitte; Franck Broly; Jean-Marc Lo-Guidice
Journal:  Mutat Res       Date:  2007-01-25       Impact factor: 2.433

5.  The cytochrome p450 homepage.

Authors:  David R Nelson
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

6.  CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China.

Authors:  Li-Dong Wang; Shu Zheng; Bin Liu; Jian-Xiang Zhou; Yan-Jie Li; Ji-Xue Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 7.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

8.  Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.

Authors:  Martin Spiecker; Harald Darius; Thomas Hankeln; Muhidien Soufi; Alexander M Sattler; Jürgen R Schaefer; Koichi Node; Jan Börgel; Andreas Mügge; Klaus Lindpaintner; Anika Huesing; Bernhard Maisch; Darryl C Zeldin; James K Liao
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

9.  CYP2F1 genetic polymorphism: identification of interethnic variations.

Authors:  G Tournel; C Cauffiez; J Leclerc; I Billaut-Laden; D Allorge; D Chevalier; F Migot-Nabias; A Kenani; F Broly; J -M Lo-Guidice
Journal:  Xenobiotica       Date:  2007-12       Impact factor: 1.908

10.  The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.

Authors:  Kefu Tang; Yang Li; Zhao Zhang; Yunmin Gu; Yuyu Xiong; Guoyin Feng; Lin He; Shengying Qin
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

View more
  2 in total

1.  Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations.

Authors:  Dmitrij Alekseevitch Sychev; Grigorij Nikolaevich Shuev; Salavat Shejhovich Suleymanov; Kristina Anatol'evna Ryzhikova; Karin Badavievich Mirzaev; Elena Anatol'evna Grishina; Natalia Evgenievna Snalina; Zhannet Alimovna Sozaeva; Anton Mikhailovich Grabuzdov; Irina Andreevna Matsneva
Journal:  Pharmgenomics Pers Med       Date:  2017-03-31

2.  Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population.

Authors:  Peilong Cao; Qian Zhao; Yuan Shao; Hua Yang; Tianbo Jin; Baiya Li; Honghui Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.